Onivyde 43 mg/10Ml Injection 1's
₹99000*
₹84150*
MRP ₹99000
15% CB
₹14850 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Onivyde 43 mg/10Ml Injection 1's belongs to a class of antineoplastic medications or chemotherapy drugs primarily used to manage or treat Colorectal cancer (Cancer that develops in the colon or rectal tissue). Colorectal cancer is a disease in which cells in the colon or rectum grow out of control.
Onivyde 43 mg/10Ml Injection 1's contains Irinotecan works by blocking an enzyme called topoisomerase I. All cells need this enzyme to divide and grow. Irinotecan blocks this enzyme so the cancer cells can not divide. As a result, Irinotecan inhibits cancer cell division and growth.
Onivyde 43 mg/10Ml Injection 1's should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. The most common adverse reactions are nausea, vomiting, abdominal pain, diarrhoea, constipation, anorexia (an eating disorder), Neutropenia (an unusually low number of cells called neutrophils), leukopenia (including lymphocytopenia), anaemia (not having enough healthy red blood cells), asthenia (abnormal weakness), fever, weight loss, alopecia (hair loss). You should talk to your doctor if you persistently experience these side effects.
Avoid using Onivyde 43 mg/10Ml Injection 1's if you are allergic to it. Onivyde 43 mg/10Ml Injection 1's can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months after the treatment. Using effective contraceptive methods is recommended while on treatment with Onivyde 43 mg/10Ml Injection 1's. Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment since it is unknown whether this medication passes into breast milk. Alcohol should be avoided during treatment with this medicine. Safety and effectiveness in children have not been established.
Onivyde 43 mg/10Ml Injection 1's is an antineoplastic medicine or chemotherapeutic treatment used to control or treat colorectal cancer (colon or rectal cancer). Onivyde 43 mg/10Ml Injection 1's contains Irinotecan acts by inhibiting an enzyme known as topoisomerase I. This enzyme is required for all cells to divide and flourish. Irinotecan inhibits this enzyme, preventing cancer cells from dividing. As a result, Irinotecan inhibits cancer cell division and growth.
Before taking the Onivyde 43 mg/10Ml Injection 1's, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Before and during your therapy, your doctor will prescribe laboratory testing on a regular basis. You may also suffer severe diarrhoea (known as ''late diarrhoea'') more than 24 hours after receiving Irinotecan. Your doctor would advise you to take antidiarrheal drugs at regular intervals throughout the day and night. When taking antidiarrheal drugs, always follow your doctor's instructions. During your therapy, your doctor will also inform you which foods to take and which to avoid to reduce diarrhoea. Drink plenty of fluids and strictly adhere to this diet.
Drug-Drug Interactions: Onivyde 43 mg/10Ml Injection 1's may interact with macrolide antibiotics (e.g. clarithromycin, erythromycin), medicines used to treat high blood pressure and to control angina (e.g. diltiazem), anti-fungal medications (e.g. itraconazole, ketoconazole) and HIV/AIDS medications (e.g. ritonavir).
Drug-Food Interactions: Avoid the consumption of alcoholic beverages and grapefruit juices.
Drug-Disease Interactions: Onivyde 43 mg/10Ml Injection 1's may interact with disease conditions, including severe renal or hepatic conditions, severe diarrhoea, bone marrow suppression, Neutropenia (An abnormally low count of a type of white blood cell), and pulmonary toxicity.
Keep all of your doctor's and laboratory appointments. Your doctor will arrange tests to assess your body's reaction to Irinotecan.
Cancer: Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Types of cancer include blood, lung, breast, etc. Cancer growth can be prevented by chemotherapy, radiation, and stem cell therapy.
Colorectal cancer: Colorectal cancer is a condition in which cells in the colon or rectum proliferate uncontrollably. It is known as colon cancer. The colon is also known as the large intestine or large bowel. The rectum is the tunnel between the colon and the anus.
Alcohol
Caution
Avoid alcohol consumption while on treatment with Onivyde 43 mg/10Ml Injection 1's.
Pregnancy
Unsafe
Onivyde 43 mg/10Ml Injection 1's should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.
Breast Feeding
Unsafe
Onivyde 43 mg/10Ml Injection 1's should not be used in breastfeeding. Discuss with your doctor if you have any concerns.
Driving
Caution
Onivyde 43 mg/10Ml Injection 1's can make you dizzy or impair your vision, especially in the first 24 hours after taking it. Do not drive or operate machinery until you know how this drug affects you.
Liver
Caution
Onivyde 43 mg/10Ml Injection 1's should be used with caution if you have liver disease. Inform your doctor before receiving the Onivyde 43 mg/10Ml Injection 1's if you have had a liver impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
It is not recommended for use in patients on dialysis. Inform your doctor before receiving the Onivyde 43 mg/10Ml Injection 1's if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Caution
Safety and effectiveness in children have not been established. Hence, use is not recommended.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information